Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 30,000 shares at $0.74 ($22K) on 2025-09-05, disclosed to the SEC on 2025-09-09.
Open-market sale of $22k NMTC by Business Development Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NMTC | SELL | 2026-03-16 | $734 | — | Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-06-05 | $6K | — | Filing → |